1. ZFTA (Zinc Finger Translocation Associated) Fusion in Supratentorial Ependymomas: Low Prevalence in South Asians and No Correlation with Survival.
- Author
-
Goyal-Honavar, Abhijit, Balasundaram, Ambritha, Thayakaran, Immanuel Paul, Babu, Malavika, Pai, Rekha, Joseph, Julie, Jayachandran, Ranjani, Chacko, Ari G., Mathew, Leni G., Balakrishnan, Rajesh, Rajshekhar, Vedantam, Jeyaseelan, L., Sudarsanam, Thambu David, and Chacko, Geeta
- Subjects
- *
ZINC-finger proteins , *CELL adhesion molecules , *SOUTH Asians , *FLUORESCENCE in situ hybridization , *NUCLEAR fusion - Abstract
Supratentorial ependymomas (STEs) are an aggressive group of ependymomas, topographically distinct from their posterior fossa and spinal counterparts. Zinc finger translocation associated (ZFTA) fusion–positive cases have been reported to account for the majority of STEs, although data on its association with poorer outcomes are inconsistent. We assessed the prevalence of the ZFTA fusion by reverse-transcription polymerase chain reaction and fluorescence in situ hybridization in a cohort of 61 patients (68 samples) with STE. Our primary outcome was to determine the role of the ZFTA fusion on progression-free and overall survival of patients with STE. Our secondary objectives were to assess the impact of ZFTA fusion on nuclear factor (NF)-kB pathway signaling via surrogate markers of this pathway, namely COX-2, CCND1, and L1 cell adhesion molecule. ZFTA fusion was noted in 21.3% of STEs in our cohort. The presence of this rearrangement did not significantly impact the progression-free or overall survival of patients with STEs and was not associated with upregulation of markers of the NF-kB pathway. Only gross total resection was significantly associated with better progression-free survival. In contradiction to previous reports from across the world, the ZFTA fusion is far less prevalent among our population. It does not appear to drive NF-kB signaling or significantly affect outcomes. Gross total resection must be attempted in all cases of STE and adjuvant radiation and/or chemotherapy employed when gross total resection is not achieved. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF